PPD achieves CEO Cancer Gold Standard Reaccreditation

CRO |  News | By BioSpectrum Bureau  | 0 Comment | 21 Jul, 2015

Pharmaceutical Product Development (PPD) has announced that it has achieved the CEO Cancer Gold Standard reaccreditation from the non-profit CEO Roundtable on Cancer for maintaining a stron...Read more

Quintiles offers a new solution to BioPharma Cos

CRO |  News | By BioSpectrum Bureau  | 0 Comment | 26 May, 2015

To help emerging biopharmaceutical companies in the Asia Pacific region, achieve their growth aspirations, Quintiles has launched a new solution set. It is tailored to meet the needs of eme...Read more

Theorem opens a new clinical supplies facility

CRO |  News | By BioSpectrum Bureau  | 0 Comment | 15 May, 2015

Theorem Clinical Research will open a new, state-of-the-art clinical supplies facility in Frankfurt, Germany, in June. The current good manufacturing practice (cGMP) compliant facility will...Read more

Quintiles most preferred CRO for phase II/III trials

CRO |  News | By BioSpectrum Bureau  | 0 Comment | 22 May, 2013

A recent report has indicated that Quintiles best differentiates itself on service quality in phase II/III clinical research. The Industry Standard Research's (ISR) 2013 CRO Quality Benchma...Read more

GVK BIO strengthens tie-up with CTC Life Science Japan

CRO |  News | By BioSpectrum Bureau  | 0 Comment | 09 Dec, 2014

The drug repurposing platform called GRIP (GVK Bio Repurposing Integrated Platform) is a combination of several GVK Bio proprietary and several public domain databases. It calls for reinves...Read more

Pfizer collaborates with NIHR Clinical Research

CRO |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jul, 2015

A new collaboration between the National Institute for Health Research Clinical Research Network (NIHR CRN) and Pfizer aims to see UK patients among the first to benefit from a new wave of ...Read more

Quintiles, Quest Diagnostics jointly launch Q2 Solutions

CRO |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jul, 2015

Quintiles and Quest Diagnostics on June 03, 2015 announced the launch of Q2 Solutions, their new combined clinical trials laboratory services organization. Q2 Solutions brings together the ...Read more

No confirmed cases of Ebola in India: WHO director

CRO |  News | 0 Comment | 26 Aug, 2014

"Despite rumors," said Dr Poonam Singh, "there have been no confirmed cases of Ebola in the eleven countries of WHO's South-East Asia Region, including India." According to Dr Singh, an Eb...Read more

“Staring at a bleak future�

CRO |  News | By Rahul Koul Koul | 0 Comment | 15 Sep, 2014

Choked by hyper activism on one side and uncertain regulations on the other, the clinical research industry in India is no longer an attraction. Despite its strengths of offering low cost E...Read more

Dr Reddy's enters into partnership with Hetero

CRO |  News | By BioSpectrum Bureau  | 0 Comment | 24 Mar, 2015

Dr Reddy's Laboratories announced that it has entered into an agreement with Hyderabad-based Hetero Drugs Limited, under which Dr Reddy's has been licensed to distribute and market Sofosbuv...Read more

SIRO Clinpharm opens new facility in Hyderabad

CRO |  News | By BioSpectrum Bureau  | 0 Comment | 11 Nov, 2014

SIRO Clinpharm announces the opening of its new office in Hyderabad, India.  "Hyderabad has always had a vibrant biopharmaceutical ecosystem and we believe that SIRO Clinpharm can actively...Read more

5 steps to strengthen approval procedures for clinical trials

CRO |  News | By BioSpectrum Bureau  | 0 Comment | 07 Mar, 2013

The government of India has taken five following steps to strengthen the approval procedures and monitoring mechanism for clinical trials of drugs in the country to ensure that safety, righ...Read more

Patients back-out from clinical trials fearing AV consent

CRO |  News | 0 Comment | 21 Aug, 2014

The discussion was led by Ms Suneela Thatte, president, ISCR, and Dr Bapsy, senior consultant and head of department, oncology, Apollo Hospitals. During the discussion, Dr Bapsy revealed th...Read more

Naz Haji takes over as head of Quintiles India

CRO |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jun, 2015

Based out of Quintiles' office in Bangalore, Mr Naz Haji will be responsible for providing vision, strategic business and technology direction, and operational capabilities to support the c...Read more

ISCR requests media to report objectively on clinical trials

CRO |  News | By Rahul Koul Koul | 0 Comment | 07 Oct, 2013

With reference to recent media reports that appeared following the PIL Hearing on Clinical Trials - Writ Petition (Civil) No(S). 33 Of 2012 - that was held on September 30, 2013, Indian Soc...Read more

It is the age of 'Digital Patient', says Quintiles

CRO |  News | By BioSpectrum Bureau  | 0 Comment | 23 Apr, 2013

A new report by Quintiles has indicated that sponsor companies that can successfully engage with the digital patient will distinguish themselves and increase their probability of success. T...Read more

India has less than 1.5% share of global clinical trials: ISCR

CRO |  News | By BioSpectrum Bureau  | 0 Comment | 18 May, 2015

ISCR is an association of clinical research professionals that aims to build awareness of clinical research as a specialty in India. A series of workshops and seminars would be held by ISCR...Read more

Biosimilars - the next emerging frontier

CRO |  Views | By BioSpectrum Bureau  | 0 Comment | 04 Feb, 2013

The first generation of biological therapeutics were developed in the 1980s. The global biological market represents one of the fastest growing sectors in the healthcare industry. With the ...Read more